yes saw that coming - don't think we would be that lucky but you never know.
the main thing is MSB hits commercialisation of its technology and its already been on the radar of big pharma with historic deals.
i think the risk is weighted to the upside and significant upside at that.
big pharma r & d is a nightmare - hit and miss - they would rather write big cheque for MSB and its pipeline of income
Chances of Covid Trial being a success, page-20
-
- There are more pages in this discussion • 82 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.020(1.72%) |
Mkt cap ! $1.318B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.20 | $1.15 | $4.221M | 3.607M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 24618 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 384 | 1 |
View Market Depth
| Last trade - 15.59pm 16/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |